- Sections
- C - Chimiemétallurgie
- C07D - Composés hétérocycliques
- C07D 209/36 - Atomes d'oxygène en position 3, p. ex. adrénochrome
Détention brevets de la classe C07D 209/36
Brevets de cette classe: 67
Historique des publications depuis 10 ans
|
4
|
7
|
5
|
3
|
2
|
4
|
5
|
3
|
5
|
1
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Musc Foundation for Research Development | 366 |
5 |
| Biosynth AG | 64 |
4 |
| Azora Therapeutics, Inc. | 13 |
4 |
| New Mexico Tech University Research Park Corporation | 52 |
3 |
| Syntara Limited | 11 |
3 |
| Amira Pharmaceuticals, Inc. | 66 |
2 |
| Beth Israel Deaconess Medical Center, Inc. | 853 |
2 |
| CFD Research Corporation | 58 |
2 |
| National University Corporation Kobe University | 569 |
2 |
| U.S. Department of Veterans Affairs | 51 |
2 |
| Boehringer Ingelheim International GmbH | 4493 |
1 |
| Centre National de La Recherche Scientifique | 11016 |
1 |
| FUJIFILM Corporation | 30512 |
1 |
| The General Hospital Corporation | 4858 |
1 |
| Georgia Tech Research Corporation | 2942 |
1 |
| The Board of Regents of the University of Oklahoma | 656 |
1 |
| Board of Trustees of Southern Illinois University | 102 |
1 |
| The Broad Institute, Inc. | 1975 |
1 |
| Cambridge Display Technology Limited | 480 |
1 |
| Clark Atlanta University, Inc. | 13 |
1 |
| Autres propriétaires | 28 |